Subacute Combined Degeneration Mimics Traumatic Spinal Cord Injury
Subacute combined degeneration (SCD) is a potentially reversible neurologic disorder caused by vitamin B12 deficiency that classically affects the dorsal columns of the spinal cord, presenting with sensory loss, gait instability, and weakness. According to a case report published in the medical literature, a 66-year-old man with a recent history of nitrous oxide use presented with bilateral lower extremity weakness, sensory changes, and gait instability, resulting in recurrent ground-level falls that initially mimicked an acute traumatic spinal cord injury (SCI).
Diagnostic Challenges and Initial Evaluation Pitfalls
Initial medical evaluations can easily miss metabolic myelopathies when patients present following physical trauma. In this case, the patient’s initial emergency department evaluation for traumatic SCI—including non-contrast CT scans of the head and cervical spine—was unremarkable, leading to a discharge home, according to the case report. Worsening weakness, progressive sensory loss to the mid-thoracic level, and sensory gait ataxia ultimately prompted a re-presentation 10 days later for advanced diagnostic workup.
Pro Tip: When evaluating patients with unexplained recurrent falls and bilateral neurologic deficits, clinicians should maintain a broad differential that includes metabolic derangements like vitamin B12 deficiency, even if initial trauma imaging is negative.
Role of MRI and Laboratory Testing in SCD Identification
Accurate diagnosis relies heavily on targeted laboratory testing and specialized neuroimaging when physical trauma is ruled out. Subsequent laboratory evaluation revealed a significant vitamin B12 deficiency secondary to pernicious anemia, while cervical MRI revealed symmetric dorsal column T2 hyperintensity in the axial plane forming the characteristic “inverted V” sign associated with SCD, as detailed in the patient’s medical records.
Did You Know? Inadequate vitamin B12 causes an accumulation of myelotoxic methylmalonic acid that preferentially attacks heavily myelinated tracts like the dorsal columns, sparing the anterior spinal cord and producing the distinctive “inverted V” sign on MRI scans.
Managing Motor and Autonomic Deficits During Rehabilitation
Recovery from subacute combined degeneration often requires intensive inpatient rehabilitation to address complex motor and autonomic symptoms. Despite serum B12 level correction through intramuscular injections, the patient experienced persistent neurologic deficits, including orthostatic hypotension that caused a 46 mmHg drop in systolic blood pressure from supine to standing, according to clinical observations. Medical management with midodrine, compression stockings, and an abdominal binder successfully stabilized his blood pressure, allowing him to complete a 12-day rehabilitation course and ambulate 200 feet with a walker.
Frequently Asked Questions
What is subacute combined degeneration (SCD)?
Subacute combined degeneration is a neurologic disorder caused by vitamin B12 deficiency that leads to the demyelination of the dorsal columns of the spinal cord.
How does nitrous oxide cause SCD?
Nitrous oxide irreversibly oxidizes and inactivates cobalamin, inhibits its biologic activity, and leads to demyelination of neurons, particularly in patients with underlying deficiencies like pernicious anemia or chronic alcohol abuse, and can trigger SCD, according to clinical literature.
What is the “inverted V” sign on an MRI?
The “inverted V” sign refers to a bilaterally symmetric hyperintensity in the cervical dorsal columns seen on axial T2-weighted MRI sequences, which serves as a hallmark imaging finding for subacute combined degeneration.
Can SCD symptoms be reversed with treatment?
Vitamin B12 supplementation can halt disease progression and improve symptoms, though delayed treatment may result in irreversible neurologic impairment and functional disability, according to medical reports.
Explore More Medical Insights
Subscribe to our newsletter to receive the latest case studies, clinical updates, and diagnostic breakthroughs directly in your inbox.
Subscribe NowRelated reading